Tuberculous Pericarditis in a Patient with Crohn’s Disease After Anti-tumor Necrosis Factor-Alpha Therapy
1Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul, Türkiye
2Department of Gastroenterology, İstanbul University, İstanbul Faculty of Medicine, İstanbul, Türkiye
2Department of Gastroenterology, İstanbul University, İstanbul Faculty of Medicine, İstanbul, Türkiye
Journal of Enterocolitis 2022; 1(1): 23-25 DOI: 10.5152/Jenterocolitis.2022.220507
Abstract
This report describes a 54-year-old female, who experiences tuberculous pericarditis after using tumor necrosis factor-alpha blocker for her diagnosis of Crohn’s disease. Following the diagnostic work-up, anti-tbc treatment was started and she had a very good response after 1 month. This case emphasizes the importance of considering the diagnosis of tuberculous pericarditis in patients who use tumor necrosis factor-alpha antagonists, even though the latent tuberculosis infection screening was negative at the beginning.
Keywords: Crohn’s disease, infliximab, pericarditis, tuberculous, tuberculosis, tumor necrosis factor inhibitors